Cambridge BioMarketing is a full-service, global healthcare marketing and communications agency. We work with clients in the pharmaceutical and biotechnology sectors, with a specialized focus on rare, orphan, and ultra-orphan conditions.
In 2017, Cambridge BioMarketing created the Emmy-nominated Rare in Common documentary. A true passion project for the agency, the film gave people from the rare disease community an opportunity to tell their stories. Today, the storytelling has expanded to the world of audio with the Rare in Common podcast. And after taking their studio on the road to speak with advocates, caregivers, and patients at the Global Genes® RARE Patient Advocacy Summit, Rare in Common is looking for more members of the rare community to tell their stories.
The Rare in Common podcast is making its debut at the 2019 ACMG Annual Clinical Genetics Meeting with a booth in the Family Advocacy Pavilion in the Exhibit Hall and a recording studio on-site during the meeting. Rare in Common wants to speak with healthcare providers, researchers, and industry professionals to capture the rare experience from all angles during the ACMG Meeting. Stop by to learn more about the documentary and podcast, Cambridge BioMarketing itself, or to inquire about time to speak with our host, Andra Stratton.